Barshay v. Naithani
Opinion
23-382 Barshay v. Naithani
UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT
SUMMARY ORDER
RULINGS BY SUMMARY ORDER DO NOT HAVE PRECEDENTIAL EFFECT. CITATION TO A SUMMARY ORDER FILED ON OR AFTER JANUARY 1, 2007, IS PERMITTED AND IS GOVERNED BY FEDERAL RULE OF APPELLATE PROCEDURE 32.1 AND THIS COURT’S LOCAL RULE 32.1.1. WHEN CITING A SUMMARY ORDER IN A DOCUMENT FILED WITH THIS COURT, A PARTY MUST CITE EITHER THE FEDERAL APPENDIX OR AN ELECTRONIC DATABASE (WITH THE NOTATION “SUMMARY ORDER”). A PARTY CITING A SUMMARY ORDER MUST SERVE A COPY OF IT ON ANY PARTY NOT REPRESENTED BY COUNSEL.
1 At a stated term of the United States Court of Appeals for the Second Circuit, 2 held at the Thurgood Marshall United States Courthouse, 40 Foley Square, in the City of 3 New York, on the 18th day of December, two thousand twenty-three. 4 5 PRESENT: 6 GERARD E. LYNCH, 7 MICHAEL H. PARK, 8 STEVEN J. MENASHI, 9 Circuit Judges. 10 _____________________________________ 11 12 Yan Barshay, 13 14 Plaintiff-Appellant, 15 16 v. 23-382 17 18 Mahesh Naithani, 19 20 Defendant-Appellee. 21 _____________________________________ 22 23 FOR PLAINTIFF-APPELLANT: GREGORY A. SIORIS, New York, NY. 24 25 FOR DEFENDANT-APPELLEE: JOSHUA L. RAY (Ellen-Louise Moens on the 26 brief) Candey LLC, New York, NY. 27 28 Appeal from a judgment of the United States District Court for the Southern District of
29 New York (Failla, J.).
1 UPON DUE CONSIDERATION, IT IS HEREBY ORDERED, ADJUDGED, AND 2 DECREED that the judgment of the district court is AFFIRMED. 3 Plaintiff-Appellant Yan Barshay brought this diversity action asserting claims for breach 4 of contract, breach of fiduciary duty, and unjust enrichment against Defendant-Appellee Mahesh 5 Naithani in October 2020, stating that Naithani breached an oral agreement to pay back a $100,000 6 loan that Barshay extended in 2003. The district court dismissed all of Barshay’s claims but 7 allowed Barshay to amend his pleadings regarding his breach of contract claim if he could allege 8 that he and Naithani had agreed to a repayment date for the loan and that Naithani had breached 9 by not paying by that date. Barshay did amend his complaint, leading to the Second Amended 10 Complaint (“SAC”) operative in this appeal. The district court dismissed the SAC as well, 11 holding that a release executed by Barshay barred his remaining claim and that Barshay still failed 12 to identify clearly when and how Naithani breached. Barshay challenges that decision on appeal. 13 We assume the parties’ familiarity with the underlying facts, the procedural history of the case, 14 and the issues on appeal. 15 “We review de novo the grant of a motion to dismiss.” Bellin v. Zucker, 6 F.4th 463, 472 16 (2d Cir. 2021). “In so doing, we must consider the complaint in its entirety, as well as other 17 sources courts ordinarily examine when ruling on Rule 12(b)(6) motions to dismiss, in particular, 18 documents incorporated into the complaint by reference, and matters of which a court may take 19 judicial notice.” Id. (internal quotation marks omitted) (quoting Kaplan v. Lebanese Canadian 20 Bank, SAL, 999 F.3d 842, 854 (2d Cir. 2021)). “We draw all reasonable inferences in the 21 plaintiff’s favor to determine whether the plaintiff stated a plausible claim to relief.” Id.
1 Barshay’s claim is based on an oral agreement struck in 2003. Naithani made two 2 payments on the loan’s principal and accrued interest, one in October 2016 and one in January 3 2018. Barshay alleges that when Naithani made the second payment, he agreed to pay a balance 4 of $250,000 upon the sale of an entity called Medmeme LLC, where Barshay and Naithani both 5 worked and where Naithani was president. 6 Around the time of that sale, Barshay executed two releases. One was titled the 7 “Confidential Settlement Agreement and General Release” (the “First Release”) and was executed 8 by Barshay and his “Employer”—a term defined as Medmeme LLC and an associated entity called 9 Pharmaspectra LLC. App’x at A40. In consideration for separation pay, Barshay agreed to 10 release Medmeme, Pharmaspectra, and their “parents, subsidiaries, affiliates, predecessors, 11 successors and any other entity related to it and all of its and their present directors, officers, 12 employees and anyone else acting for any of them” “from all claims of any type to date, known or 13 unknown, suspected or unsuspected, arising out of anything to do with your employment, the end 14 of your employment, or any other matter.” Id. The First Release also contained a merger clause 15 that stated that: “This Agreement is the complete understanding between you and the Employer. 16 It replaces any other agreements, representations or promises, written or oral.” Id. at A43. 17 Barshay signed this release on October 4, 2019. Id. at A44. 18 The other release (the “Second Release”) states in full:
19 In consideration of full payment by Medmeme LLC, a Delaware limited liability 20 company, Pharmaspectra LLC, a Delaware limited liability company, Medical 21 Intelligence Solutions LLC, a Delaware limited liability company, and Mahesh 22 Naithani, an individual (collectively, the “Borrowers”), in the amount of One 23 Thousand One Hundred Dollars ($1,100) on the date set forth above, I, Yan 24 Barshay, referred to as the Lender, release and discharge the Borrowers from any 25 claims, liabilities, or obligations of the Borrowers to the Lender.
Free access — add to your briefcase to read the full text and ask questions with AI
Barshay v. Naithani (Barshay v. Naithani) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.